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Summary 
Clonal deletion via activation-induced apoptosis (AIA) of antigen-specific T  cells (ASTC) plays 
a very important role in the induction  of peripheral tolerance. However, none of the studies 
performed so far has shown a complete deletion ofASTC,, a small population always persisting 
in the periphery. The mechanism by which this small population of ASTC escapes AIA has not 
been determined.  Since the existence of these ASTC may influence the outcome of autoim- 
mune diseases and long-term graft survival, we have characterized the properties of these resid- 
ual ASTC in vivo with the objective of determining mechanisms that may contribute to their 
persistence. It was found that the resistance of the residual ASTC to AIA is not due to lack of 
activation or Fas/Fas-L expression. Compared to those susceptible to AIA, the residual ASTC 
express a high level of Th2-type cytokines that may help them to escape from AIA. Further- 
more, they are able to suppress proliferation of other ASTC, suggesting they may, in fact, pro- 
long tolerance in vivo. 
R 
ecent studies have demonstrated that the in vivo en- 
counter with antigen following injection of bacterial 
superantigens (1-3)  or allogenic cells  (4) into normal mice 
or injection (5-9)  or feeding (10)  of transgenic mice with 
specific antigens leads to a deletion of the majority of anti- 
gen-specific T  cells  (ASTC) 1 in the periphery by a process 
termed activation-induced apoptosis (AIA). However, the 
deletion has never been complete. There is always a small 
percentage  (~10-30%  of total)  of ASTC  that  are  able  to 
escape from AIA and persist in the periphery of the host. 
The persistence of this small population of ASTC does not 
seem to  depend  on  the  type  of antigen  used  (SEB,  Mls, 
MHC,  or FLY), route of antigen administration  (oral, i.p., 
or i.v.) or the dosage of antigen used (1-9). A similar phe- 
nomenon has also been observed after in vitro induction of 
apoptosis in mature peripheral T  cells  and T  cell hybrido- 
mas (11-18). 
Why do T  cells that possess the same Ag specificity and 
phenotype (CD4 or CDS) undergo a different fate after en- 
countering antigen? What are the important factors in de- 
termining whether or not a T  cell dies? To date, studies on 
peripheral tolerance have focused only on the majority of 
dying cells.  No  systematic studies have been done on the 
residual cells  to reveal the mechanism why these  cells  are 
1Abbreviations used in this paper: AIA, activation-induced apoptosis; ASTC, 
antigen-specific T cells; dm2, BALB/c H-2-dm2. 
capable  of escaping  AIA,  and  their  function,  if any,  in 
maintaining tolerance in vivo is not clear. In this paper we 
study the molecular, cellular, and functional characteristics 
of the apoptosis-resistant ASTC in vivo to delineate possible 
mechanisms by which some ASTC can escape from clonal 
deletion whereas others undergo apoptosis. We found that 
there was no significant  difference between apoptosis-resistant 
and  -sensitive  ASTC  in  terms  of activation  or  Fas/Fas-L 
expression. However, there was a difference in their cytokine 
expression: apoptosis-resistant ASTC expressed significantly 
higher  levels  of IL-4  and  [L-10  than  apoptosis-sensitive 
ASTC. Functional studies revealed that the apoptosis-resis- 
tant ASTC have become unresponsive to further Ag stimu- 
lation, in vivo and in vitro, and that they can suppress the 
activation of other ASTC. 
Materials and Methods 
Mice and Adoptive  Transfer.  C57BL/6  (B6), (B6xBALB/c)F1 
(BYJ F1)  and  BALB/c  H-2-dm2  (din2) mice were  purchased 
from Jackson Laboratories  (Bar Harbor, ME). Breading  stock of 
2C transgenic mice were kindly provided by Dr. Dennis Y. Loh 
(Howard Hughes Medical Institute, St. Louis). A large fraction of 
T  cells in the periphery of the 2C mouse (H-2  be~ express a Tg 
TCR. reactive against the L  a class I MHC antigen. These T cells can 
be detected by a  clonotypic  mAb  1B2  and  are  predominantly 
CD8  + (19, 20). 2C transgenic mice were first backcrossed onto B6 
mice for 6-8 generations  to obtain the transgene on B6 (H-2  b/b) 
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mutant) to obtain 2CF1 mice (H-2  b/a, L a-, 1B2 +) and used as lym- 
phocyte donors. C.B-17 scid (effectively BALB/c congenic to B6 at 
the IgH locus, H-2  a/a) and B6 scid (H-2  b/b) mice were bred in the 
animal colony at the Ontario Cancer Institute. scidFl mice (H-2  b/a, 
L a+) were obtained by breeding C.B-17 scid mice with B6 scid 
mice and used as recipients. Viable lymphocyte suspensions were 
prepared from spleen and pooled axillary, inguinal, and mesen- 
teric LN of 2CF1 mice and injected i.v. into scidF1 mice (3--4 ￿ 
107 cells/mouse). 
Cell Surface Marker Staining.  To follow the fate of adoptively 
transferred ASTC in vivo, lymphocytes from LN and spleen of 
recipient mice were collected and analyzed at different times after 
injection. Lymphocytes were stained with biotinylated 1B2 mAb 
(which  recognize the  transgenic TCR.;  hybridoma kindly pro- 
vided by Dr.  Herman Eisen, MIT)  and FITC-conjugated anti- 
CD8  (Pharmingen,  San Diego,  CA)  followed by staining with 
streptavidin red 670 (GIBCO BILL, Gaithersburg). Data were ac- 
quired and analyzed using FACScan  |  Lysis II software (Becton 
Dickinson, Mountain View, CA). 
Staining of Antigen-specific Apoptotic Ceils.  To  detect apoptotic 
antigen specific T  cells in vivo, we have developed a technique 
which combines cell surface  marker staining with an in situ nick 
translation assay, as described elsewhere (21).  Briefly, following 
surface  marker staining, cells were fixed, permeabilized and then 
incubated with Pol I and biotin-conjugated-nucleotide. Cells con- 
taining DNA breaks were then visualized by the fluorescent de- 
tection of the newly synthesized biotin-containing DNA. Fluo- 
rescence is limited to the nucleus of the cell. Cell surface staining 
using FITC  and Red670-1abeled monoclonal antibodies before 
fixation for nick translation makes it possible to define which cell 
subsets are undergoing apoptosis in the whole population. 
Cell Sorting and Cytotoxicity  Assay.  4 wk after transfer, lympho- 
cytes from the spleen ofscidFi mice were stained with mAbs 1B2 
and CD8 as described above. IB2+CD8 + cells were sorted by us- 
ing a cell sorter (Coulter Epics, Hialeah, FL), and the sorted cells 
were used as responder cells in a cytotoxicity assay. Varying num- 
bers of responder cells (from 10-10S/well) were cocultured with 
irradiated (20 Gy) F1  (BALB/cxB6) splenocytes (H-2  b/a, L a§  in 
ot-MEM supplemented with 10% FCS in the presence or absence 
of 25 U/m] rlL-2. After 5 d of culture, percentage lysis of specific 
target cells was measured by SlCr release assay. 
Purification of 1B2+  CD8 + Cells by Magnetic Beads.  After lysing 
red  blood cells,  lymphocytes were  incubated  with  anti-mouse 
IgG(H+L)-coated  magnetic  beads  (Advanced  Magnetic,  Inc., 
Cambridge, MA). The supematant, containing less than 2% B cells, 
was harvested after placing the cell suspension in a magnetic field. 
Since almost all CD8 + cells are 1B2 +, to isolate IB2+CD8 + cells, 
the B-depleted cells were incubated with an anti-CD8 biotiny- 
lated antibody followed by incubation with streptavidin coated 
magnetic  beads  (Dynal  A.S.;  Oslo,  Norway).  Almost  all  the 
CD8 + cells (>99%) can bind to the beads and will be held by the 
magnetic field. The bead-binding cells were more than 95% pure 
1B2+CD8 + cells and more than 98% viable. 
Determination of mRNA  Levels of Cytokines and  Fas/Fas-L  by 
RT-PCR.  Total RNA was extracted from purified 1B2+CD8 § 
cells (5  X  106) with TriZol reagent (GIBCO BRL). cDNA was 
prepared from RNA with 50 pmol oligo(dT)18 and 200 units of 
routine MLV  reverse transcriptase (GIBCO BILL);  2  Ixl of the 
cDNA mixture was used in a PCR reaction with 10 pmol of for- 
ward and reverse primers and 2.5  U  of Taq  DNA polymerase 
(Perkin-Elmer Cetus, Norwalk, CT). The sequences of the spe- 
cific sense and anti-sense oligonucleotide primer pairs, 5' and 3' 
were as follows (22-27): IL-2, 5'-ATGTACAGCATGCAGCTC- 
GCATCCTGTGTC-3'  and 5'-CTGCTTGGGCAAGTAAAA- 
TTTGAAGGTGAGC-3';  IL-4,  5'-ATGGGTCTCAACCCC- 
CAGCTAGTTGTC-3' and 5'-CTTCGTTGCTGTGAGGAC- 
GTTTGGCAC-3';  IL-10,  5'-CCCAGAAATCAAGGAGCA- 
TTTG-3';  and 5'-CATATGCTTCTATGCAGTTG-3'; IFN-~/, 
5'-CTTCTTGGATATCTGGAGGAACTGGCAAAA-3'  and 
5'-CTCAAACTTGGCAATACTCATGAATGCATC-3  ';  FAS, 
5'-ATCCGAGCTCTGAGGAGGCGGGTTCATGAAAC-3'  and 
5'-GGAGGTTCTAGATTCAGGGTCATCCTG-3';  FAS-L, 
5'-CAGCTCTTCCACCTGCAGAAGG-3'  and  5'-AGATTC- 
CTCAAAATTGATCAGAGAGAG-3'.  ]3-actin,  5'-ATGGAT- 
GACGATATCGCT-3' and 5'-ATGAGGTAGTCTGTCAGGT- 
3'.  Samples were  amplified through  30  cycles at  an  annealing 
temperature of 58~  in a  PCR  Thermal  Cycler (Perkin-Ehner 
Cetus). The products were separated on agarose gel by electro- 
phoresis and stained with ethidium bromide. The  specificity of 
the  reactions was  confirmed by direct sequencing of the  PCIk 
products with a  cyclic sequencing kit  (Stratagene  Inc.,  LaJolla, 
CA).  Semiquantitative analysis  of the  mRNA  levels of IFN-% 
IL-2, IL-4, IL-10, Fas, Fas-L, and ]3-actin was performed by RT- 
PCR at varying time points. 
Results 
Establishment of  An Adoptive  Transfer System.  Since in most 
previous studies antigens were  introduced into  adult mice 
that possessed a  large number  of ASTC  (1-3,  6-10),  it is 
possible that some ASTC persisted simply because they did 
not have  a  chance to contact the antigen due  to a limited 
quantity  and/or  half-life of the  antigen.  To  exclude  this 
possibility, we have established an adoptive transfer system. 
B62C  mice were  bred with  din2 mice  (a BALB/c L d loss 
mutant). The subsequent 2CF1 mice, which were H-2  b/d, L d-, 
1B2 +, were used as lymphocyte donors. A limited number, 
3-4  millions,  of viable  1B2+CD8 +  cells from  2Cvl  mice 
were  intravenously  injected  into  a  scidF1 mouse  (H-2  b/d, 
L a+, obtained by breeding C.B-17 scid with B6 scid mice). 
A  group  of B6-scid mice  (H-2  b/b,  L a-) were  injected with 
the same number of 1B2+CD8 + cells from B62C  (H-2 b/b) 
transgenic mice as negative controls, In this system the only 
immunological  response  was  that  of 1B2+CD8 +  cells  of 
donor origin to the L d antigen expressed on the recipients, 
since scid mice exhibit defective recombination of antigen 
receptor genes leading to  an  early arrest in  T  and B  lym- 
phocyte development, allowing for survival and growth of 
transplanted foreign cells. In addition, constant  expression 
of the L a Ag on all the nucleated cells in scidF~ guaranteed 
the persistence of a  high dose of Ag and  greatly increased 
the chance for 1B2+CD8 + cells to encounter the L a antigen. 
Activation,  Proliferation and  Apoptosis  of the  Majority  and 
Persistertce of the Minority of ASTC  after Encountering  Ag  In 
Vivo.  The fate of 1B2+CD8 + cells was followed in recip- 
ient scidrl mice  in  vivo  after  adoptive  transfer.  The  total 
number of 1B2+CD8 + cells started to increase in both LN 
and spleen 3  d  after transfer into scidFl mice and reached 
a  peak  by  5  d.  1  wk  after  transfer,  the  total  number  of 
1B2+CD8 + cells started to decline in the periphery. By 2 wk, 
the majority (less than 10% of peak number) of 1B2+CD8 + 
2066  Characterization ofApoptosis-resistant  T Cells In Vivo cells  had  disappeared  from  the  periphery.  However,  the 
disappearance  of ASTC  was  not  complete.  There  were 
~20--30%  of ASTC persistent in the periphery for at least 
2 wk after injection (Fig.  1 A,  top).  No  significant change 
in either tlre total numbers of 1B2+CD8 -  (Fig.  1) or 1B2- 
CD8-  cells in  the  same  animal  or of 1B2+CD8 +  cells in 
the B6 scid control mice could be observed (not shown). 
To  see  whether  the  loss  of  1B2+CD8 +  cells  in  sddrl 
mice was  due  to  death by AIA in vivo after encountering 
antigen, we developed a technique in which staining of cell 
surface markers is combined with the detection of nuclear 
DNA  strand breaks. This allows one to detect apoptosis in 
a  defined lymphocyte population in vivo at the single cell 
level (21).  Using this technique, we found that before en- 
countering  antigen,  there  was  a  low number  of apoptotic 
cells in  each  subset,  which  may represent either a  normal 
rate of cell death in the 2C mice or background staining. 3 d 
after encountering  antigen in  vivo,  marked  apoptosis was 
detected  in  1B2+CD8 +  cells  but  not  in  1B2+CD8 -  or 
1B2-CD8- cells. 2 wk after injection, very few apoptotic cells 
could be detected. (Fig. 1 A, bottom).  This finding was con- 
firmed by staining cells before and 5  d  after injection with 
Acridine Orange. As shown in Fig.  1 B, before encounter- 
ing  antigen,  no  apoptotic  cells  could  be  seen  (Fig.  1  a). 
However, 5 d after injection, a high proportion of cells dis- 
played nuclear chromatin  condensation  and fragmentation 
(Fig.  1  b).  These results provide direct evidence that after 
encountering antigen in vivo, there is a transient expansion 
followed by AIA of the majority, and persistence of the mi- 
nority of ASTC in the periphery. As the sCidFx mice are of 
BALB/c background, they constitutively express the L a an- 
tigen on all nucleated cells, therefore make it unlikely that 
some ASTC survived due to failure to encounter antigen. 
Persistence of Some ASTC  Is Not  Due  to  Lack of Antigen- 
presenting  Cells.  Another  possibility could  be  that  some 
ASTC survive AIA because the activated 1B2+CD8 +  cells 
Figure 1.  Activation induced apoptosis in the majority, and persistence of a small population of ASTC after encountering antigen in vivo. (A) scidF1 
mice were injected with 3 ￿  107 viable lymphocytes containing 12-15% 1B2+CD8  + cells from 2CF1 mice. LN and spleen from scidr  mice were col- 
lected on days 0, 3, and 14 after injection and lymphocytes were stained for the transgenic TCP,, CD8, and DNA nicks as described in Materials and 
Methods. Data were acquired and analyzed on a FACScan  |  using Lysis  II software. The dot plots of anti-CD8 vs 1B2 staining can be divided into three 
regions as indicated in the top panel: region 1 (R1), 1B2+CD8  - cells, region 2 (R2), 1B2+CD8  + cells and region 3 (1L3), 1B2-CD8- cells. Each of these 
regions was separately analyzed for the presence of DNA nicks (bottom) where percentages ofapoptotic cells in each region are indicated. (B) Acridine 
Orange staining oflymphocytes from scidrl mice before (a) and 5 d after injection (b). 
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so that the rest of the  1B2+CD8 +  cells could not be acti- 
vated and  deleted.  If this were  the  case,  splenocytes from 
scidFl mice  that received transgenic  cells previously would 
not act as good stimulators in an MLR.  To  test this possi- 
bility, LNC  from 2CF1  mice were  used  as responders and 
stimulated by irradiated splenocytes from  scidF1 mice  that 
had  been  injected with  1B2+CD8 +  cells 2  wk  earlier,  or 
from  naive scid mice  as control.  As shown  in  Fig.  2,  cells 
from both injected and naive scidF1 mice were  equally ef- 
fective in  stimulating the  generation  of cytotoxic T  cells. 
These  experiments  demonstrate  that  the  fact  that  some 
ASTC survive AIA is not due to lack of antigen presenting 
cells in  the  recipient and  suggest that residual cells them- 
selves may possess different cellular or molecular characters 
from those susceptible to AIA. 
Persistence of Some  ASTC  Is  Not  Due  to  Lack  of Activa- 
tion.  Since it has been reported that not all ASTC can be 
activated after encountering antigen in vivo (28), it is possible 
that  some  ASTC  escape  AIA not  because  these  cells  are 
more resistant to apoptosis but because they are unable to be 
activated due  to  lack  of receptors for  co-stimulators. Ac- 
cordingly, we examined residual ASTC for a  set of T  cell 
activation markers.  15 d  after receiving 2CF1  cells, lympho- 
cytes were collected from scidFl mice and triple stained with 
mAbs specific for 1B2 and CD8 in combination with one of 
the following T  cell activation markers: pgp-1, MEL 14, or 
Fas. The expression levels of those activation markers on the 
residual 1B2§  + cells were compared to naive 1B2+CD8 + 
cells (Fig. 3). The results are summarized in Table 1. There 
is a clearly increased expression ofpgp-1  and decreased ex- 
pression of MEL  14 on the residual 1B2+CD8 + cells com- 
pared to  that  on  the  naive  1B2+CD8 +  cells. After activa- 
tion,  the  percentage  of Fas  +  cells was  also  increased  (not 
shown).  This increase was more marked for the percentage 
of Fas  high+ cells. These data strongly suggest that the resid- 
ual  1B2+CD8 §  cells have  in  fact been  activated after  en- 
countering the L a antigen in vivo. 
Persistence of Some ASTC  Is Not Due to Lack of Fas/Fas-L 
Expression.  Recendy,  many  studies  have  shown  that  in- 
teraction between  Fas and  Fas-hgand  (Fas-L) plays an im- 
portant role in AIA in mature T  lymphocyte both in vitro 
(16-18)  and in  vivo  (25,  26,  29-31).  We  therefore  asked 
whether some ASTC survived AIA because of a lack of or 
downregulation  of Fas  and/or  Fas-L  expression.  To  test 
this,  1B2+CD8 +  cells were  first purified from scidFi mice 
on day 0,  5,  and 21  after injection and their expression of 
Fas and Fas-L mRNA  was  compared using RT-PCR..  As 
shown in Fig. 4, lanes 2-4, naive 1B2+CD8 + cells express a 
low level of Fas mRNA,  but no detectable Fas-L mRNA. 
5  d  after encountering antigen in vivo, both Fas and Fas-L 
expression were  significandy increased  (lanes  5-7),  which 
may account for the marked apoptosis detected in ASTC at 
this time. Interestingly, at 3 wk after injection, the levels of 
expression of both Fas and Fas-L mRNA  were still high in 
the remaining resting 1B2+CD8 + cells, although a little less 
than at 5  d after injection (lane 8-10). 
Expression  of Fas  on  the  1B2+CD8 +  cells  at  different 
times  after injection was  also analyzed by flow cytometry 
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Figure 2.  Persistence of some ASTC is not due to lack of antigen-pre- 
senting cells. Splenocytes from 2C~1 mice were stimulated by irradiated 
(20Gy) splenocytes from scidvl mice either  uninjected or injected with 
2Crl  cells 2 wk previously￿9  Percentage lysis  of specific target cells was 
measured by SICr release assay  after 5 d culture. Data are plotted as per- 
centage specific killing vs number  of IB2+CD8 § cells/well. Each data 
point represents five replicates. 
Figure 3.  Expression  of activation markers on 1B2+CD8  + cells. Lym- 
phocytes from sdd~l were stained with 1B2 and CD8 followed by staining 
one of the activation markers. Pgp-1, MEL-14, and Fas  high histograms are 
of gated 1B2+CD8  + cells. Lymphocytes from day 0 (grey areas) are com- 
pared to that 15 d after injection of 2CFt cells (areas within black lines). 
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CD8  + Cells 
LN  Spleen 
Activation 
markers  Day 0  Day 15  Day 0  Day 15 
Pgpl +  30.5  +  3.3  88.7  -+ 0.7  20.7  +  3.9  85.6  +  2.1 
MEL 14 +  28.6  •  1.0  12.0 +  0.7  26.2  +  4.2  16.5 +  0.2 
Fas  high+  7.3 +_  1.0  28.8  +  4.5  7.7  •  0.5  15.4 •  3.6 
and the correlation between the percentage of Fas  high+ cells 
and the percentage of apoptotic cells was studied. As shown 
in Fig.  5,  the percentage  of Fas  high+ cells increased about 
fourfold on day 5, fivefold on day 10 and fivefold on day 
15 in LNC compared to what was found on day 0. There 
was no correlation between the percentages of Fas  high+ cells 
and the percentage of apoptotic  cells  (Fig.  5).  These data 
strongly argue against the possibility that some ASTC sur- 
vived AIA due to a lack of Fas (Fig. 5) or Fas-L (Fig. 4) ex- 
pression and indicate that to die or not to die is not solely 
dependent on Fas/Fas-L expression, suggesting that  addi- 
tional  regulatory  factors  are  involved in  the  survival  of 
ASTC after tolerance induction. 
Apoptosis-resistant  ASTC  Express  High  Levels  of Th2-like 
Cytokines.  Next, we examined the pattern of cytokine ex- 
pression in apoptosis-resistant ASTC. Purified 1B2+CD8 + 
cells from scidF1 mice on day 0, 5, and 21  after injection of 
2CF1  cells  were  obtained and  total  RNA  was  extracted. 
The expression levels ofmRNA  for IFN-% IL-2, IL-4, and 
IL-10  were  determined by  a  semiquantatative RT-PCR 
(Fig. 4). It was found that, except for IFN-% naive ASTC 
did not express detectable cytokine mRNA.  5  d  after en- 
countering Ag  in  vivo,  significant levels  of mRNA  for 
IFN-',/ and IL-2 were  detected but there was  no mRNA 
for IL-4 or IL-10, i.e., the ceils exhibited a Thl-hke pat- 
tern of cytokine expression (32,33). In contrast, the surviv- 
ing 1B2+CD8 + cells expressed high levels of both IL-4 and 
IL-10 mRNA, i.e., the cells exhibited a Th2-1ike pattern of 
cytokine  expression  (32,33).  These  results  indicate  that 
CD8 +  cells can produce Thl-  or Th2-1ike cytokines, and 
suggest that  ASTC which  express  Th2-1ike cytokines are 
more resistant to AIA than those that express Thl-like cy- 
tokines. 
Unresponsiveness  of the Apoptosis-resistant  ASTC  to Ag Re- 
stimulation In  Vitro and In  Vivo.  To  characterize  the  bio- 
logical function of apoptosis-resistant ASTC, we  first ex- 
amined their ability to generate cytotoxic T  cells in vitro. 
Purified residual 1B2+CD8 + cells from sddF1 mice 1 wk after 
injection were cultured with irradiated (B6xBALB/c)F  1 sple- 
nocytes in the presence of exogenous rlL-2 and compared 
to the response of naive 1B2+CD8  + cells. The latter could 
kill L a+  target cells whereas the former did not show any 
cytotoxicity to L  a+ cells even in the presence of exogenous 
IL-2  (Fig.  6).  When the  unsorted remaining 1B2+CD8 + 
cells from scidFl mice 4 wk after injection were tested in the 
same way,  similar results were  found (not shown). These 
data indicate that after AIA, the surviving cells can not kill 
antigen specific targets in vitro even in the presence of ex- 
ogenous IL-2. 
The functional status of the residual cells was also exam- 
ined in vivo by secondary transfer of the  residual ASTC 
into naive scidFl mice 4 d after receiving lymphocytes from 
Figure 4.  Residual  ASTC express Fas/Fas-L  as well as IL-4 and IL-10. 
Total RNA was extracted from purified IB2+CD8  + cells (5 ￿  106) on 
days 0,  5,  and 21.  Semiquantitative analysis of the  mRNA levels of 
IFN-~, IL-2, IL-4, IL-10, Fas, Fas-L, and I~-actin  was performed by RT- 
PCR at varying time points: lanes 2-4, day 0; lanes 5-7, day 5; lanes 
8--10, day 21; lane 1, molecular  markers. Each time point contained sam- 
pies obtained from three different  mice. 
Figure 5.  No correlation between % Fas  high+ and % nick  + cells after 
encounter with Ag in vivo. Lymphocytes  were collected from sdd~ mice 
on days 0, 5, 10, and 15 after transfer and stained for Fas with PE-conju- 
gated anti-Fas mAb or for DNA nicks as described in Fig. 1 B. Percent- 
ages of Fas  hies+ and nick  + cells in LN were plotted. Each time point con- 
tains data from 2-5 mice. Similar results were obtained in spleen (not 
shown). 
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Figure 6.  Residual ASTC did not kill target cells bearing L  d Ag in the 
presence of exogenous IL-2. 1 wk after transfer, residual 1B2+CD8  § cells 
(Exp) were purified by cell sorting from scid  H mice, and naive 1B2+CD8  + 
cells  were  also purified  as  controls. Varying  numbers of  purified 
1B2+CD8 + cells were cocultured with irradiated (20 Gy) (BALB/cxB6)F  1 
splenocytes (H-2  b/a, L  d*) in ~x-MEM supplemented with 10% FCS in the 
present of 25 U rlL-2. Percentage lysis of specific target cells was mea- 
sured by 5~Cr release  assay  after 5 d culture. Data are plotted as percentage 
specific killing vs number of 1B2+CD8 + cells/well. Each data point rep- 
resents five replicates. 
2C~1  mice.  As controls,  age- and  sex-matched scidF1 mice 
were injected with the same number of naive lymphocytes 
from  2CF1  mice.  4  d  after transfer,  LNC  and  splenocytes 
from  scidFl  mice were  stained with mAbs against  1B2  and 
CD8.  Unlike in the control scidF1 mice that received naive 
1B2+CD8 +  cells, LNC  and  splenocytes in  the scidF1 mice 
that received residual  1B2+CD8 §  cells did not show blast 
transformation, and the percentage of 1B2+CD8 + cells was 
significantly lower than that in the control mice (Fig. 7 A). 
Similar experiments  were  performed  18  d  after  receiving 
lymphocytes from 2CF1 mice and 3  d  after secondary trans- 
fer, and the same results were obtained (Fig. 7 B). Both ex- 
periments showed that the residual 1B2+CD8 + cells prolif- 
erated little, if at all, after being transferred into naive scidF1 
mice that provided new source of Ag and APC.  These re- 
sults not  only support the  notion  that persistence of some 
of ASTC  after AIA is not  due  to  lack of antigen/antigen 
presenting cells, but  also argues  against the  residual  1B2 + 
CD8 §  cells being traditional memory cells (34). 
Apoptosis-resistant  ASTC  Possess  Suppressive  Function  In 
Vivo.  To  see  whether  the  residual ASTC  have  any  im- 
munoregulatory role in vivo, scidrl mice were injected with 
3  ￿  107  viable lymphocytes from  2CF1  mice.  15  d  later, 
these scicl  H  mice were given a second injection of the same 
number  of viable naive lymphocytes from 2Crl  mice.  5  d 
after the second injection, the total numbers of 1B2+CD8 + 
cells  in  LN  and  spleen  were  compared  to  those  of scidF1 
which received only one injection 5  or 20 d  before. It was 
found  that  the  total  number  of  1B2+CD8 +  cells  in  the 
scidF1 mice which  received two  injections was  comparable 
to the scidFT mice which received one injection 20 d before, 
Figure 7.  Non-responsiveness of residual ASTC in vivo upon antigen 
restimulation. (A)  ScidH  mice were injected with 2CF1 lymphocytes. 4  d 
after injection  recipient  mice were  killed  and viable lymphocytes were 
isolated and transferred into new sddFl  mice  (3  ￿  10V/mouse) (grey  bar, 
experimental group). On the same day of the secondary transfer, another 
four naive scidvt  mice were each injected with 3  ￿  107 freshly collected 
2CF1 cells as  day four controls  (white  bar).  After another 4  d,  LNC and 
splenocytes were  collected from both  groups of mice and stained with 
anti-lB2 and anti-CD8. Data were analyzed on two-color flow cytome- 
try.  Mean percentage of 1B2+CD8 + cells in LN and spleen are shown. 
(B) The same experiment was performed 18 d after the first injection and 
3 d after the secondary transfer. 
but significantly lower than observed in the scidF~ mice that 
received only one injection 5  d  earlier (Fig. 8).  When  the 
remaining ASTC were mixed with naive  1B2+CD8 +  cells 
(at  1:1  ratio)  and injected into  naive scidF1 mice,  the  total 
number of 1B2+CD8 + cells in spleen and LN 5  d  after in- 
jection  was  found  to  be  significantly lower  than  in  those 
mice that received the same number  of naive  1B2+CD8 + 
cells alone  (not shown).  These  data suggest that prolifera- 
tion  of newly injected  1B2§  +  cells in  vivo  has  been 
suppressed by the residual Th2-1ike ASTC. 
Discussion 
There  are  two published studies using adoptive transfer 
systems  to  study the  fate  of ASTC  in  vivo  (5,  7).  Rocha 
and von Boehmer  (5)  transferred anti-male HY transgenic 
T  cells into male nude mice that carry male HY Ag. Kear- 
2070  Characterization ofApoptosis-resistant  T Cells In Vivo Figure 8.  Inhibition of  ASTC response to L  d antigen in vivo by residual 
cells. ScidF1 mice were injected with 3 ￿  107 2CF1 cells. 15 d after injec- 
tion, some of  them were left for another 5 d without the second injection 
(grey bar); some received a second injection of 3 ￿  107 2C cells (hatched 
bar). At the time, another group of naive scidF1 mice were injected with 
the same number of cells from the same donors as controls (clear bar). 4 d 
later,  all  mice were killed and  the  total number  of 1B2+CD8  + and 
1B2+CD8  - cells in LN were analyzed  by flow cytometry. 
ney et  al.  (7)  transferred  limiting  number  of anti-chicken 
ovalbumin peptide  TCR. transgenic  cells into normal syn- 
genic BALB/c mice and then exposed the recipients to the 
peptide  Ag in vivo.  In both  systems,  it was observed that 
ASTC initially proliferated extensively after encounter with 
Ag. Most of the ASTC then rapidly  disappeared  from the 
periphery,  leaving  behind  a  population  that  was  hypo- 
responsive  to antigenic  restimulation.  We  have  confirmed 
these  findings  in  a  different  adoptive  transfer  system  and 
have  extended  their  studies  by further  characterization  of 
the  remaining ASTC in terms  of their  activation markers, 
Fas/Fas-L expression,  cytokine profiles,  and their effect on 
naive ASTC in vivo. 
We  have  demonstrated  that  the  small  population  of 
ASTC that was able to escape from AIA did not do so due 
to  a  lack of activation  or lack of Fas/Fas-L  expression  on 
these  cells.  Our  finding  that  high  levels  of Fas  and  Fas-L 
expression could be observed both at an early stage after ac- 
tivation and on the residual ASTC at later times suggests that 
expression of Fas/Fas-L may be important in the induction 
of some but not all ASTC death in our system.  This result 
is  consistent  with  findings  that  peripheral  T  cell  deletion 
takes place in lpr mice, and autoimmune syndromes occur 
in mouse strains without Fas or Fas-L defects (35, 36). Re- 
cently,  Zheng et  al.  (35)  found that  Fas/Fas-L interaction 
alone  accounted  for  almost  all  CD4  +  T  cell  apoptosis, 
whereas  tumor  necrosis  factor  caused  most  CD8 +  T  cell 
death  in vitro.  Since  in  our system the  ASTC  are  CD8 + 
ceils,  it is possible' that the remaining 1B2+CD8 + cells may 
use a different pathway (i.e.,  tumor necrosis factor) for au- 
toregulatory apoptosis. 
It has been reported that cytokines are involved in regu- 
lation  of apoptosis  in both  T  and B  lymphocytes in vitro 
(37--41). For instance, interferon ~/(IFN-~/) has been shown 
to promote  cell death induced by anti-TCR mAbs in  the 
absence  of costimulatory  cells  (37).  IL-10  could  prevent 
apoptosis in EBV infected human T  cells in vitro  (38, 39). 
So far,  however,  no in vivo study has shown a  correlation 
between  cytokine  production  pattern  and  apoptosis.  The 
fact that high levels  of IL-4 and  IL-10 could only be  ob- 
served on the residual AIA-resistant ASTC, but not on the 
naive  or  early  activated  ASTC  suggests  that  Th2-1ike 
CD8 + cells are more resistant to AIA than Thl-hke CD8 + 
cells.  Currently, it is not clear what determines that a T  cell 
to  expresses  high  levels  of IL-4/IL-10.  It  is  possible  that 
high levels of expression of mP,  NA oflL-4 and IL-10 is the 
consequence  of selective  deletion  of Thl-like  cells  or  of 
conversion of Th0 or Thl-like cells  into Th2-1ike cells.  As 
regards to what role IL-4/IL-10 could play in AIA in vivo, 
it is possible that Th2-like cytokines might serve as "salva- 
tion signals." After activation and expression of Fas/Fas-L, 
a death signal may be transduced if no further salvation sig- 
nal is provided. However, if a salvation signal (IL-10/IL-4?) 
is supplied, it may block the death signal and help T  cells  to 
escape from AIA. Further studies such as blocking IL-4/IL-10 
by anti-IL-4/IL-10 mAbs would help in delineating the role 
ofTh2-1ike cytokines in preventing apoptosis. 
Another interesting finding in this study is that the resid- 
ual  1B2+CD8 +  cells  could  inhibit  proliferation  of naive 
1B2+CD8 +  cells  in  vivo,  which  suggests  that  Th2-1ike 
CD8 +  cells  may function as suppressor cells.  Our prelimi- 
nary studies  have indicated  an enhanced  (over  100  d)  L  a+ 
skin  graft  survival  in  the  presence  of the  residual  iB2 + 
CD8 + cells.  Further studies should delineate the underlying 
mechanism of this suppression.  Taken together, these stud- 
ies not only open a new window for our understanding of 
the  mechanisms  involved  in  the  induction  of peripheral 
tolerance,  but may have  potential  therapeutic  applications 
in both autoimmune diseases and long-term graft rejection. 
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